img

Global Adgre1 Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Adgre1 Market Research Report 2024

ADGRE1 (Adhesion G Protein-Coupled Receptor E1) is a Protein Coding gene. Among its related pathways are GPCR downstream signalling and Class A/1 (Rhodopsin-like receptors). Gene Ontology (GO) annotations related to this gene include G protein-coupled receptor activity and transmembrane signaling receptor activity. An important paralog of this gene is ADGRE2.
According to MRAResearch’s new survey, global Adgre1 market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Adgre1 market research.
In terms of regions, North America is expected to remain the largest market for Adgre1 during the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Adgre1 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bio-Rad
Thermo Fisher Scientific
R&D Systems
Lifespan Biosciences
Genetex
Atlas Antibodies
Abbexa Ltd
BioLegend
Segment by Type
Above 90%
Above 95%
Above 99%
Others

Segment by Application


Biopharmaceutical Companies
Bioscience Research Institutions
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Adgre1 report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adgre1 Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Above 90%
1.2.3 Above 95%
1.2.4 Above 99%
1.2.5 Others
1.3 Market by Application
1.3.1 Global Adgre1 Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Biopharmaceutical Companies
1.3.3 Bioscience Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Adgre1 Market Perspective (2018-2033)
2.2 Adgre1 Growth Trends by Region
2.2.1 Global Adgre1 Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Adgre1 Historic Market Size by Region (2018-2023)
2.2.3 Adgre1 Forecasted Market Size by Region (2024-2033)
2.3 Adgre1 Market Dynamics
2.3.1 Adgre1 Industry Trends
2.3.2 Adgre1 Market Drivers
2.3.3 Adgre1 Market Challenges
2.3.4 Adgre1 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adgre1 Players by Revenue
3.1.1 Global Top Adgre1 Players by Revenue (2018-2023)
3.1.2 Global Adgre1 Revenue Market Share by Players (2018-2023)
3.2 Global Adgre1 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adgre1 Revenue
3.4 Global Adgre1 Market Concentration Ratio
3.4.1 Global Adgre1 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adgre1 Revenue in 2022
3.5 Adgre1 Key Players Head office and Area Served
3.6 Key Players Adgre1 Product Solution and Service
3.7 Date of Enter into Adgre1 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adgre1 Breakdown Data by Type
4.1 Global Adgre1 Historic Market Size by Type (2018-2023)
4.2 Global Adgre1 Forecasted Market Size by Type (2024-2033)
5 Adgre1 Breakdown Data by Application
5.1 Global Adgre1 Historic Market Size by Application (2018-2023)
5.2 Global Adgre1 Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Adgre1 Market Size (2018-2033)
6.2 North America Adgre1 Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Adgre1 Market Size by Country (2018-2023)
6.4 North America Adgre1 Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Adgre1 Market Size (2018-2033)
7.2 Europe Adgre1 Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Adgre1 Market Size by Country (2018-2023)
7.4 Europe Adgre1 Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adgre1 Market Size (2018-2033)
8.2 Asia-Pacific Adgre1 Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Adgre1 Market Size by Region (2018-2023)
8.4 Asia-Pacific Adgre1 Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Adgre1 Market Size (2018-2033)
9.2 Latin America Adgre1 Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Adgre1 Market Size by Country (2018-2023)
9.4 Latin America Adgre1 Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adgre1 Market Size (2018-2033)
10.2 Middle East & Africa Adgre1 Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Adgre1 Market Size by Country (2018-2023)
10.4 Middle East & Africa Adgre1 Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Detail
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Adgre1 Introduction
11.1.4 Bio-Rad Revenue in Adgre1 Business (2018-2023)
11.1.5 Bio-Rad Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Adgre1 Introduction
11.2.4 Thermo Fisher Scientific Revenue in Adgre1 Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 R&D Systems
11.3.1 R&D Systems Company Detail
11.3.2 R&D Systems Business Overview
11.3.3 R&D Systems Adgre1 Introduction
11.3.4 R&D Systems Revenue in Adgre1 Business (2018-2023)
11.3.5 R&D Systems Recent Development
11.4 Lifespan Biosciences
11.4.1 Lifespan Biosciences Company Detail
11.4.2 Lifespan Biosciences Business Overview
11.4.3 Lifespan Biosciences Adgre1 Introduction
11.4.4 Lifespan Biosciences Revenue in Adgre1 Business (2018-2023)
11.4.5 Lifespan Biosciences Recent Development
11.5 Genetex
11.5.1 Genetex Company Detail
11.5.2 Genetex Business Overview
11.5.3 Genetex Adgre1 Introduction
11.5.4 Genetex Revenue in Adgre1 Business (2018-2023)
11.5.5 Genetex Recent Development
11.6 Atlas Antibodies
11.6.1 Atlas Antibodies Company Detail
11.6.2 Atlas Antibodies Business Overview
11.6.3 Atlas Antibodies Adgre1 Introduction
11.6.4 Atlas Antibodies Revenue in Adgre1 Business (2018-2023)
11.6.5 Atlas Antibodies Recent Development
11.7 Abbexa Ltd
11.7.1 Abbexa Ltd Company Detail
11.7.2 Abbexa Ltd Business Overview
11.7.3 Abbexa Ltd Adgre1 Introduction
11.7.4 Abbexa Ltd Revenue in Adgre1 Business (2018-2023)
11.7.5 Abbexa Ltd Recent Development
11.8 BioLegend
11.8.1 BioLegend Company Detail
11.8.2 BioLegend Business Overview
11.8.3 BioLegend Adgre1 Introduction
11.8.4 BioLegend Revenue in Adgre1 Business (2018-2023)
11.8.5 BioLegend Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Adgre1 Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Above 90%
Table 3. Key Players of Above 95%
Table 4. Key Players of Above 99%
Table 5. Key Players of Others
Table 6. Global Adgre1 Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Adgre1 Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Adgre1 Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Adgre1 Market Share by Region (2018-2023)
Table 10. Global Adgre1 Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Adgre1 Market Share by Region (2024-2033)
Table 12. Adgre1 Market Trends
Table 13. Adgre1 Market Drivers
Table 14. Adgre1 Market Challenges
Table 15. Adgre1 Market Restraints
Table 16. Global Adgre1 Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Adgre1 Market Share by Players (2018-2023)
Table 18. Global Top Adgre1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adgre1 as of 2022)
Table 19. Ranking of Global Top Adgre1 Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Adgre1 Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Adgre1 Product Solution and Service
Table 23. Date of Enter into Adgre1 Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Adgre1 Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Adgre1 Revenue Market Share by Type (2018-2023)
Table 27. Global Adgre1 Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Adgre1 Revenue Market Share by Type (2024-2033)
Table 29. Global Adgre1 Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Adgre1 Revenue Market Share by Application (2018-2023)
Table 31. Global Adgre1 Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Adgre1 Revenue Market Share by Application (2024-2033)
Table 33. North America Adgre1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Adgre1 Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Adgre1 Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Adgre1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Adgre1 Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Adgre1 Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Adgre1 Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Adgre1 Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Adgre1 Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Adgre1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Adgre1 Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Adgre1 Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Adgre1 Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Adgre1 Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Adgre1 Market Size by Country (2024-2033) & (US$ Million)
Table 48. Bio-Rad Company Detail
Table 49. Bio-Rad Business Overview
Table 50. Bio-Rad Adgre1 Product
Table 51. Bio-Rad Revenue in Adgre1 Business (2018-2023) & (US$ Million)
Table 52. Bio-Rad Recent Development
Table 53. Thermo Fisher Scientific Company Detail
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Adgre1 Product
Table 56. Thermo Fisher Scientific Revenue in Adgre1 Business (2018-2023) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. R&D Systems Company Detail
Table 59. R&D Systems Business Overview
Table 60. R&D Systems Adgre1 Product
Table 61. R&D Systems Revenue in Adgre1 Business (2018-2023) & (US$ Million)
Table 62. R&D Systems Recent Development
Table 63. Lifespan Biosciences Company Detail
Table 64. Lifespan Biosciences Business Overview
Table 65. Lifespan Biosciences Adgre1 Product
Table 66. Lifespan Biosciences Revenue in Adgre1 Business (2018-2023) & (US$ Million)
Table 67. Lifespan Biosciences Recent Development
Table 68. Genetex Company Detail
Table 69. Genetex Business Overview
Table 70. Genetex Adgre1 Product
Table 71. Genetex Revenue in Adgre1 Business (2018-2023) & (US$ Million)
Table 72. Genetex Recent Development
Table 73. Atlas Antibodies Company Detail
Table 74. Atlas Antibodies Business Overview
Table 75. Atlas Antibodies Adgre1 Product
Table 76. Atlas Antibodies Revenue in Adgre1 Business (2018-2023) & (US$ Million)
Table 77. Atlas Antibodies Recent Development
Table 78. Abbexa Ltd Company Detail
Table 79. Abbexa Ltd Business Overview
Table 80. Abbexa Ltd Adgre1 Product
Table 81. Abbexa Ltd Revenue in Adgre1 Business (2018-2023) & (US$ Million)
Table 82. Abbexa Ltd Recent Development
Table 83. BioLegend Company Detail
Table 84. BioLegend Business Overview
Table 85. BioLegend Adgre1 Product
Table 86. BioLegend Revenue in Adgre1 Business (2018-2023) & (US$ Million)
Table 87. BioLegend Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adgre1 Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Adgre1 Market Share by Type: 2022 VS 2033
Figure 3. Above 90% Features
Figure 4. Above 95% Features
Figure 5. Above 99% Features
Figure 6. Others Features
Figure 7. Global Adgre1 Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Adgre1 Market Share by Application: 2022 VS 2033
Figure 9. Biopharmaceutical Companies Case Studies
Figure 10. Bioscience Research Institutions Case Studies
Figure 11. Others Case Studies
Figure 12. Adgre1 Report Years Considered
Figure 13. Global Adgre1 Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Adgre1 Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Adgre1 Market Share by Region: 2022 VS 2033
Figure 16. Global Adgre1 Market Share by Players in 2022
Figure 17. Global Top Adgre1 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adgre1 as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Adgre1 Revenue in 2022
Figure 19. North America Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Adgre1 Market Share by Country (2018-2033)
Figure 21. United States Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Adgre1 Market Share by Country (2018-2033)
Figure 25. Germany Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Adgre1 Market Share by Region (2018-2033)
Figure 33. China Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Adgre1 Market Share by Country (2018-2033)
Figure 41. Mexico Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Adgre1 Market Share by Country (2018-2033)
Figure 45. Turkey Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Adgre1 Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Bio-Rad Revenue Growth Rate in Adgre1 Business (2018-2023)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Adgre1 Business (2018-2023)
Figure 49. R&D Systems Revenue Growth Rate in Adgre1 Business (2018-2023)
Figure 50. Lifespan Biosciences Revenue Growth Rate in Adgre1 Business (2018-2023)
Figure 51. Genetex Revenue Growth Rate in Adgre1 Business (2018-2023)
Figure 52. Atlas Antibodies Revenue Growth Rate in Adgre1 Business (2018-2023)
Figure 53. Abbexa Ltd Revenue Growth Rate in Adgre1 Business (2018-2023)
Figure 54. BioLegend Revenue Growth Rate in Adgre1 Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed